Patrick Thompson

945 total citations
25 papers, 644 citations indexed

About

Patrick Thompson is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Patrick Thompson has authored 25 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Patrick Thompson's work include Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Patrick Thompson is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Patrick Thompson collaborates with scholars based in United States, Canada and Malaysia. Patrick Thompson's co-authors include Susan M. Blaney, Xiao‐Nan Li, Jack M. Su, Stacey L. Berg, Milton J. Finegold, Ashish M. Ingle, Ching-Nan Ou, Peter C. Adamson, Ching C. Lau and Heidi V. Russell and has published in prestigious journals such as Hepatology, Clinical Cancer Research and Neuro-Oncology.

In The Last Decade

Patrick Thompson

23 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Thompson United States 15 299 192 143 96 82 25 644
Ofelia Cruz Spain 17 163 0.5× 183 1.0× 182 1.3× 199 2.1× 62 0.8× 69 778
Arun Rangaswami United States 14 263 0.9× 233 1.2× 315 2.2× 125 1.3× 149 1.8× 35 1.1k
Hiroshi Moritake Japan 17 301 1.0× 181 0.9× 110 0.8× 119 1.2× 78 1.0× 80 874
H Weinstein United States 13 158 0.5× 199 1.0× 80 0.6× 235 2.4× 85 1.0× 24 720
Nalini Jayaprakash United States 16 226 0.8× 197 1.0× 82 0.6× 256 2.7× 49 0.6× 21 825
Kwai Han Yoo South Korea 15 183 0.6× 270 1.4× 90 0.6× 210 2.2× 83 1.0× 50 588
Dong Soo Suh South Korea 19 376 1.3× 435 2.3× 67 0.5× 140 1.5× 166 2.0× 80 1.2k
Isamu Sugiura Japan 17 172 0.6× 187 1.0× 293 2.0× 49 0.5× 27 0.3× 80 1.2k
Wim Wynendaele Belgium 10 303 1.0× 303 1.6× 49 0.3× 138 1.4× 182 2.2× 25 696
Milica C̆olović Serbia 17 261 0.9× 205 1.1× 252 1.8× 56 0.6× 61 0.7× 86 981

Countries citing papers authored by Patrick Thompson

Since Specialization
Citations

This map shows the geographic impact of Patrick Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Thompson more than expected).

Fields of papers citing papers by Patrick Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Thompson. The network helps show where Patrick Thompson may publish in the future.

Co-authorship network of co-authors of Patrick Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Thompson. A scholar is included among the top collaborators of Patrick Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Thompson. Patrick Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinsey, Carolyn, et al.. (2023). Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy. Journal of Pediatric Hematology/Oncology. 45(7). e921–e923.
2.
3.
Oesterheld, Javier, Damon R. Reed, Bhuvana A. Setty, et al.. (2020). Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric Blood & Cancer. 67(7). e28370–e28370. 16 indexed citations
4.
Baxter, Patricia, Jack M. Su, Arzu Onar‐Thomas, et al.. (2020). A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro-Oncology. 22(6). 875–885. 66 indexed citations
5.
Zdanski, Carlton J., et al.. (2019). Idiopathic, Refractory Sweet’s Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review. Current Allergy and Asthma Reports. 19(6). 32–32. 9 indexed citations
6.
Naqvi, Kiran, Elias Jabbour, Kelly E. Anderson, et al.. (2019). PS1180 FOLLOW‐UP OF LOWER DOSE DASATINIB 50MG DAILY AS FRONTLINE THERAPY IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML‐CP). HemaSphere. 3(S1). 537–537. 1 indexed citations
7.
Thompson, Patrick, et al.. (2017). Surgical Management of Fifth Metatarsal Diaphyseal Fractures: A Retrospective Outcomes Study. The Journal of Foot & Ankle Surgery. 56(3). 463–467. 11 indexed citations
8.
Sumazin, Pavel, Yidong Chen, Lisa R. Treviño, et al.. (2016). Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 65(1). 104–121. 142 indexed citations
9.
10.
Pignatelli, Ricardo H., Patrick Thompson, Qiqiong Cui, et al.. (2015). Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy. Pediatric Cardiology. 36(8). 1610–1616. 40 indexed citations
11.
Su, Jack M., Patrick Thompson, Xiao‐Nan Li, et al.. (2014). A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†. Neuro-Oncology. 16(12). 1661–1668. 55 indexed citations
12.
Bernhardt, M. Brooke, Brady S. Moffett, Michael L. Johnson, et al.. (2014). Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatric Blood & Cancer. 62(1). 80–84. 14 indexed citations
13.
Thompson, Patrick, Heather E. Wheeler, Shannon M. Delaney, et al.. (2014). Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children’s Oncology Group. Cancer Chemotherapy and Pharmacology. 74(4). 831–838. 24 indexed citations
14.
Masand, Prakash, et al.. (2014). Angiosarcoma successfully treated with liver transplantation and sirolimus. Pediatric Transplantation. 18(4). E114–9. 15 indexed citations
15.
Su, Jack M., Xiao‐Nan Li, Patrick Thompson, et al.. (2010). Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report. Clinical Cancer Research. 17(3). 589–597. 88 indexed citations
16.
Bomgaars, Lisa, et al.. (2008). Valacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatric Blood & Cancer. 51(4). 504–508. 15 indexed citations
17.
Kilburn, Lindsay, Peter L. Bonate, Susan M. Blaney, et al.. (2008). Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates. Cancer Chemotherapy and Pharmacology. 64(2). 335–340. 2 indexed citations
18.
Neville, Kathleen, Susan M. Blaney, Mark L. Bernstein, et al.. (2004). Pharmacokinetics of O6-benzylguanine in Pediatric Patients with Central Nervous System Tumors. Clinical Cancer Research. 10(15). 5072–5075. 9 indexed citations
19.
Neville, Kathleen, Robert A. Parise, Patrick Thompson, et al.. (2004). Plasma and Cerebrospinal Fluid Pharmacokinetics of Imatinib after Administration to Nonhuman Primates. Clinical Cancer Research. 10(7). 2525–2529. 53 indexed citations
20.
Thompson, Patrick, Frank M. Balis, Stacey L. Berg, et al.. (2003). Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer. Cancer Chemotherapy and Pharmacology. 52(5). 417–423. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ofelia Cruz Breakdown of academic impact, for papers by Arun Rangaswami Breakdown of academic impact, for papers by Hiroshi Moritake Breakdown of academic impact, for papers by H Weinstein Breakdown of academic impact, for papers by Nalini Jayaprakash Breakdown of academic impact, for papers by Kwai Han Yoo Breakdown of academic impact, for papers by Dong Soo Suh Breakdown of academic impact, for papers by Isamu Sugiura Breakdown of academic impact, for papers by Wim Wynendaele Breakdown of academic impact, for papers by Milica C̆olović
Rankless by CCL
2026